Virtual Medicinal Product (VMP) - Lazertinib 240mg tablets
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Lazertinib 240mg tablets | Start Date 29-04-2025 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- L01EB09
| Code | Start Date | End Date |
|---|---|---|
| 45010711000001102 | 29-04-2025 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Lazertinib mesilate monohydrate | Based on Base Substance | Lazertinib | 240 mg |
Name
Lazertinib mesilate monohydrate
Basis of strength description
Based on Base Substance
BOSS
Lazertinib
Strength and UOM (Nmr)
240.0
Strength and UOM (Dmr)
Parent Products
-
VTMLazertinib
-
VMP(Current) Lazertinib 240mg tablets
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 28 tablet |